Duloxetine Hydrochloride Enteric-coated Capsule

DRUG2 trials

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Jiangsu Nhwa Pharmaceutical Co., Ltd.

Conditions

Major Depressive DisorderMajor Depressive Disorder (MDD)

Phase 2

A Phase II Study to Evaluate NH102 for Depression

CompletedNCT06842992

Jiangsu Nhwa Pharmaceutical Co., Ltd.Major Depressive Disorder (MDD)

Start: 2024-12-04End: 2025-09-12Updated: 2025-12-01

Phase 3

Study of Desvenlafaxine in Treating Major Depressive Disorder.

CompletedNCT04364997

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Major Depressive Disorder

Start: 2020-06-18End: 2021-09-22Updated: 2021-12-03